Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ US https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Trump takes credit for Pfizer vaccine development, says Americans still won’t have one without his leadership

Trump takes credit for Pfizer vaccine development, says Americans still won’t have one without his leadership



President Trump said Friday that the United States would not have a coronavirus vaccine on the road if it were not in the Oval Office to monitor its development.

“We are far ahead with vaccines,” Trump told a White House news conference. “You wouldn’t have a vaccine if I hadn’t been for me for another 4 years.”

The president reasoned that the Food and Drug Administration could never do what he required of them to speed up the process.

Through Operation Warp Speed, the Trump administration is coordinating and investing in the accelerated development of a vaccine – with the ambitious goal of having 300 million doses of a safe vaccine by January.

EXCHANGE TARGETS OF MEDICINAL PRICES OF MEDICINES WITH COST-CUTTING MEASURES

Pfizer and partner BioNTech SE said they applied for emergency use on Friday after clinical trial data showed their vaccine was 95% effective in preventing infection, with no serious safety concerns.

Moderna announced earlier this week that the vaccine applicant is shy of 95% efficiency and the company is expected to apply for an emergency use permit soon.

The promising news comes as the United States prepares for painful months ahead amid a sharp resurgence of confirmed cases. This week, the country surpassed the dark stage, with data showing that more than 254,000 Americans have fallen victim to the virus since the outbreak.

Click here to get the FOX NEWS app

Trump made the comment when he announced several new cost-cutting measures designed to reduce the prices of prescription drugs.

The measures include ending the rebates granted to pharmacy managers, linking the prices paid for Medicare medicines to the prices paid for the same medicines in other countries, and ending the non-approved medicines initiative.

The president said large pharmaceutical companies, such as Pfizer, had delayed the promising results of vaccine attempts until after the election because his administration had taken steps to reduce drug prices to the detriment of large pharmaceutical companies.

Pfizer said the timing of the results had nothing to do with election day.


Source link